In this study, durable responses to bortezomib were registered in 60% of multi-refractory iTTP patients, with mild-to-moderate toxicities.
www.jthjournal.org/article/S153...
#MedSky #HemeSky #TTP #bortezomib
In this study, durable responses to bortezomib were registered in 60% of multi-refractory iTTP patients, with mild-to-moderate toxicities.
www.jthjournal.org/article/S153...
#MedSky #HemeSky #TTP #bortezomib
Learn more in this Review. https://ja.ma/4kc5qF1
Learn more in this Review. https://ja.ma/4kc5qF1
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
I had to draw it.
#ittp #fnaf
I had to draw it.
#ittp #fnaf
Learn more in this Review. ja.ma/3H9b4tv
Learn more in this Review. ja.ma/3H9b4tv
@cam.ac.uk @labliston.bsky.social @liverpooluni.bsky.social @ukri.org
@cam.ac.uk @labliston.bsky.social @liverpooluni.bsky.social @ukri.org
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
It seems worthy to look at anti-13 antibody during the follow-up of #iTTP . Maybe to guide anti-CD20 therapy ?
#Medsky
@amjh.bsky.social
onlinelibrary.wiley.com/doi/10.1002/...
🧵8/16
🧵8/16
@DrXLongZheng and team report on iTTP and ADAMTS13!
@DrXLongZheng and team report on iTTP and ADAMTS13!
Steven
Please
Steven
Please
#ASNKidneyNews
#ASNKidneyNews
edhub.ama-assn.org/jn-learning/...
edhub.ama-assn.org/jn-learning/...
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/fullarticle/2834159
by Pishko AM, Li A and Cuker A in JAMA #MedSky
👉 get more here
📖 read the article: https://jamanetwork.com/journals/jama/fullarticle/2834159
todos los acuerdos de la UE benefician a los mismos.
todos los acuerdos de la UE benefician a los mismos.